• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对欧洲委员会文件《内分泌干扰物的现状评估》的批判

A critique of the European Commission document, "State of the Art Assessment of Endocrine Disrupters".

机构信息

Gradient, 20 University Road, Cambridge, MA 02138, USA.

出版信息

Crit Rev Toxicol. 2012 Jul;42(6):465-73. doi: 10.3109/10408444.2012.690367. Epub 2012 May 26.

DOI:10.3109/10408444.2012.690367
PMID:22630047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3408894/
Abstract

In this commentary, we critique a recently finalized document titled "State of the Art Assessment of Endocrine Disrupters" (SOA Assessment). The SOA Assessment was commissioned by the European Union Directorate-General for the Environment to provide a basis for developing scientific criteria for identifying endocrine disruptors and reviewing and possibly revising the European Community Strategy on Endocrine Disrupters. In our view, the SOA Assessment takes an anecdotal approach rather than attempting a comprehensive assessment of the state of the art or synthesis of current knowledge. To do the latter, the document would have had to (i) distinguish between apparent associations of outcomes with exposure and the inference of an endocrine-disruption (ED) basis for those outcomes; (ii) constitute a complete and unbiased survey of new literature since 2002 (when the WHO/IPCS document, "Global Assessment of the State-of-the-Science of Endocrine Disruptors" was published); (iii) consider strengths and weaknesses and issues in interpretation of the cited literature; (iv) follow a weight-of-evidence methodology to evaluate evidence of ED; (v) document the evidence for its conclusions or the reasoning behind them; and (vi) present the evidence for or reasoning behind why conclusions that differ from those drawn in the 2002 WHO/IPCS document need to be changed. In its present form, the SOA Assessment fails to provide a balanced and critical assessment or synthesis of literature relevant to ED. We urge further evidence-based evaluations to develop the needed scientific basis to support future policy decisions.

摘要

在这篇评论中,我们对最近完成的一份名为“内分泌干扰物现状评估”(SOA 评估)的文件进行了批评。SOA 评估是由欧盟环境总局委托进行的,旨在为确定内分泌干扰物的科学标准以及审查和可能修订欧洲共同体内分泌干扰物战略提供依据。在我们看来,SOA 评估采取了轶事方法,而不是试图对现状进行全面评估或综合当前知识。为了做到后者,该文件将不得不 (i) 区分结果与暴露之间的明显关联和对这些结果的内分泌干扰 (ED) 基础的推断;(ii) 构成自 2002 年以来(当时发布了世界卫生组织/国际化学品安全规划署的“内分泌干扰物现状全球评估”文件)新文献的完整和无偏见调查;(iii) 考虑引用文献的优缺点和解释问题;(iv) 采用证据权重方法评估 ED 的证据;(v) 记录其结论的证据或背后的推理;以及 (vi) 说明需要改变与 2002 年世界卫生组织/国际化学品安全规划署文件中得出的结论不同的结论的证据或背后的推理。就目前的形式而言,SOA 评估未能提供对 ED 相关文献的平衡和批判性评估或综合。我们敦促进行进一步的基于证据的评估,以发展支持未来政策决策所需的科学依据。

相似文献

1
A critique of the European Commission document, "State of the Art Assessment of Endocrine Disrupters".对欧洲委员会文件《内分泌干扰物的现状评估》的批判
Crit Rev Toxicol. 2012 Jul;42(6):465-73. doi: 10.3109/10408444.2012.690367. Epub 2012 May 26.
2
Response to A critique of the European Commission Document, "State of the Art Assessment of Endocrine Disrupters" by Rhomberg and colleagues--letter to the editor.对罗姆伯格及其同事对欧盟委员会文件《内分泌干扰物的技术现状评估》的批评的回应——致编辑的信
Crit Rev Toxicol. 2012 Oct;42(9):787-9; author reply 790-1. doi: 10.3109/10408444.2012.712943. Epub 2012 Aug 20.
3
Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors.科学与内分泌干扰物政策必须分开:对毒理学杂志编辑的“常识性”干预的回应。
Environ Health. 2013 Aug 27;12:69. doi: 10.1186/1476-069X-12-69.
4
Identification, assessment and management of "endocrine disruptors" in wildlife in the EU substance legislation--discussion paper from the German Federal Environment Agency (UBA).欧盟物质法规中的野生动物“内分泌干扰物”的识别、评估和管理——德国联邦环境署(UBA)的讨论文件。
Toxicol Lett. 2013 Dec 16;223(3):306-9. doi: 10.1016/j.toxlet.2013.03.004. Epub 2013 Mar 15.
5
Meeting report: international workshop on endocrine disruptors: exposure and potential impact on consumers health.会议报告:内分泌干扰物国际研讨会:暴露情况及其对消费者健康的潜在影响。
Regul Toxicol Pharmacol. 2013 Feb;65(1):7-11. doi: 10.1016/j.yrtph.2012.11.010. Epub 2012 Dec 2.
6
[Endocrine disrupters: from research to risk assessment].[内分泌干扰物:从研究到风险评估]
Epidemiol Prev. 2009 Jan-Apr;33(1-2):5-7.
7
Revising the EU strategy on endocrine disruptors: nearing a decisive moment.修订欧盟内分泌干扰物战略:接近关键时刻。
J Epidemiol Community Health. 2013 May;67(5):383-4. doi: 10.1136/jech-2012-201747. Epub 2012 Nov 9.
8
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
9
European Union's strategy on endocrine disrupting chemicals and the current position of Slovenia.欧盟关于内分泌干扰化学物质的战略及斯洛文尼亚的当前立场。
Arh Hig Rada Toksikol. 2016 Jun 1;67(2):99-105. doi: 10.1515/aiht-2016-67-2728.
10
Endocrine disrupters as obesogens.作为致肥胖物的内分泌干扰物。
Mol Cell Endocrinol. 2009 May 25;304(1-2):19-29. doi: 10.1016/j.mce.2009.02.018. Epub 2009 Mar 9.

引用本文的文献

1
Endocrine disrupting chemicals in the pathogenesis of hypospadias; developmental and toxicological perspectives.尿道下裂发病机制中的内分泌干扰化学物质:发育学和毒理学观点
Curr Res Toxicol. 2021 Apr 1;2:179-191. doi: 10.1016/j.crtox.2021.03.004. eCollection 2021.
2
Evidence of the Possible Harm of Endocrine-Disrupting Chemicals in Humans: Ongoing Debates and Key Issues.内分泌干扰化学物质对人类可能造成危害的证据:持续的争论及关键问题
Endocrinol Metab (Seoul). 2018 Mar;33(1):44-52. doi: 10.3803/EnM.2018.33.1.44.
3
Metabolism disrupting chemicals and metabolic disorders.干扰新陈代谢的化学物质与代谢紊乱
Reprod Toxicol. 2017 Mar;68:3-33. doi: 10.1016/j.reprotox.2016.10.001. Epub 2016 Oct 17.
4
Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals.利用系统评价进行内分泌干扰化学物质的危害和风险评估。
Rev Endocr Metab Disord. 2015 Dec;16(4):273-87. doi: 10.1007/s11154-016-9334-7.
5
A path forward in the debate over health impacts of endocrine disrupting chemicals.关于内分泌干扰化学物质对健康影响的争论中的前进之路。
Environ Health. 2014 Dec 22;13:118. doi: 10.1186/1476-069X-13-118.

本文引用的文献

1
Response to A critique of the European Commission Document, "State of the Art Assessment of Endocrine Disrupters" by Rhomberg and colleagues--letter to the editor.对罗姆伯格及其同事对欧盟委员会文件《内分泌干扰物的技术现状评估》的批评的回应——致编辑的信
Crit Rev Toxicol. 2012 Oct;42(9):787-9; author reply 790-1. doi: 10.3109/10408444.2012.712943. Epub 2012 Aug 20.
2
Hypothesis-based weight-of-evidence evaluation of the neurodevelopmental effects of chlorpyrifos.基于假设的证据权重评估方法评估毒死蜱对神经发育的影响。
Crit Rev Toxicol. 2011 Nov;41(10):822-903. doi: 10.3109/10408444.2011.616877.
3
The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments.人类相关效力阈值:通过人类对累积风险评估的校准来降低不确定性。
Regul Toxicol Pharmacol. 2012 Mar;62(2):313-28. doi: 10.1016/j.yrtph.2011.10.012. Epub 2011 Oct 28.
4
Pharmacokinetics of bisphenol A in neonatal and adult CD-1 mice: inter-species comparisons with Sprague-Dawley rats and rhesus monkeys.双酚 A 在新生和成年 CD-1 小鼠与 Sprague-Dawley 大鼠和恒河猴中的药代动力学:种间比较。
Toxicol Lett. 2011 Dec 15;207(3):298-305. doi: 10.1016/j.toxlet.2011.09.020. Epub 2011 Sep 29.
5
Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans.药代动力学建模:预测和评估猴体内双酚 A 的途径依赖性剂量学,外推至人体。
Toxicol Appl Pharmacol. 2011 Nov 15;257(1):122-36. doi: 10.1016/j.taap.2011.08.026. Epub 2011 Sep 2.
6
Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program.基于假设的证据权重框架,用于评估美国环保署内分泌干扰物筛选计划中的数据。
Regul Toxicol Pharmacol. 2011 Nov;61(2):185-91. doi: 10.1016/j.yrtph.2011.07.007. Epub 2011 Jul 23.
7
Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure.高膳食暴露条件下人体尿液和血清中双酚 A 的 24 小时含量变化。
Toxicol Sci. 2011 Sep;123(1):48-57. doi: 10.1093/toxsci/kfr160. Epub 2011 Jun 24.
8
Is exposure to formaldehyde in air causally associated with leukemia?--A hypothesis-based weight-of-evidence analysis.空气中甲醛暴露是否与白血病有因果关系?——基于假设的证据权重分析。
Crit Rev Toxicol. 2011 Aug;41(7):555-621. doi: 10.3109/10408444.2011.560140. Epub 2011 Jun 2.
9
Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference.毒理学与流行病学:通过构建整合毒理学与流行病学证据以确立因果推断的框架来提高科学水平。
Toxicol Sci. 2011 Aug;122(2):223-34. doi: 10.1093/toxsci/kfr113. Epub 2011 May 10.
10
Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A.对双酚 A 暴露对人体健康危害的关键证据进行批判性评估。
Crit Rev Toxicol. 2011 Apr;41(4):263-91. doi: 10.3109/10408444.2011.558487.